Table 1 -. Sociodemographic and clinical characteristics of the study participants.
Patient characteristic | n | % |
---|---|---|
Age, years | ||
< 65 | 6 | 37.5 |
≥ 65 | 10 | 62.5 |
Gender | ||
Male | 9 | 56.3 |
Female | 7 | 43.8 |
Race | ||
White | 9 | 56.3 |
Black | 3 | 18.8 |
Others | 4 | 25.0 |
Histological type of NSCLC | ||
Adenocarcinoma | 9 | 56.3 |
Others | 7 | 43.8 |
Stage at diagnosis | ||
IIIB | 6 | 37.5 |
IV | 10 | 62.5 |
Performance status | ||
1 | 12 | 75.0 |
2 | 4 | 25.0 |
Comorbidities | ||
Yes | 9 | 56.3 |
No | 7 | 43.8 |
Number of drugs used | ||
< 4 | 1 | 6.3 |
5-7 | 9 | 56.3 |
8-10 | 6 | 37.5 |
Family history of cancer | ||
Yes | 8 | 50.0 |
No | 8 | 50.0 |
History of smoking | ||
Yes | 13 | 81.3 |
No | 3 | 18.8 |
History of alcoholism | ||
Yes | 8 | 50.0 |
No | 8 | 50.0 |
NSCLC: non-small cell lung carcinoma.